Developer docs
API playgroundTry for free, no card

Search company profiles

Anatomic

Full company profile

uuid000c15s

Namestring
Anatomic
Legal namestring
Anatomic Incorporated
Websiteurl
anatomic.tech
Company typeenum
Private
Founded yearint
2018
Short descriptiontext

Anatomic is a Minneapolis biotech (founded 2018) that sells hiPSC-derived neural cells, differentiation kits, and custom services to academic and pharma researchers, using a proprietary protocol that accelerates neuron production to roughly 7 days versus conventional ~1 month timelines.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMinneapolis, United States
HQ citystring
Minneapolis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
stem cell products, neuroscience research tools, hiPSC differentiation, pharma research reagents, cell therapy manufacturing
Industry1 code
PRIMARYHLAAAMAL
Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Stem Cell Research Products
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Cryopreserved hiPSC-Derived Cells
TypeOne Time License
Description

Sale of off-the-shelf cryopreserved human iPSC-derived neural cells including Sensory Neurons, Motor Neurons, Schwann Cell Precursors, Melanocytes, and Dorsal Horn Neurons for immediate use by researchers.

anatomic.com
2Differentiation Kits
TypeOne Time License
Description

Human pluripotent stem cell differentiation medium for the rapid manufacture of various neural cell types. Products include Sensory Neuron, Motor Neuron, Schwann Cell Precursor, and Melanocyte differentiation kits.

anatomic.com
3Custom Differentiation Services
TypeProfessional Services
Description

Bespoke cell differentiation services delivering specific neural cell types with rapid 6-8 week turnaround time. Provides Schwann cells, motor neurons, sensory neurons, melanocytes, and dorsal horn neurons to customer specifications.

anatomic.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Anatomic is a biotechnology company that develops and sells cryopreserved human induced pluripotent stem cell (hiPSC)-derived neural cells and differentiation kits, including sensory neurons, motor neurons, Schwann cell precursors, melanocytes, and dorsal horn neurons, for use by academic and pharmaceutical researchers in basic science and drug discovery. Its proprietary differentiation platform produces Primal Ectoderm within 24 hours and immature neurons within seven days, cutting traditional manufacturing timelines by roughly 75%. The company also offers custom differentiation services with a 6–8 week turnaround for researchers requiring bespoke cell production.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Neuron production time reduced from 1 month to 1 week (75% reduction)
+2 more records
Product overview1 text field

Anatomic is a biotech company offering a dual-product portfolio focused on accelerated production of hiPSC-derived neurons and related cell types. The portfolio consists of cryopreserved cells (ready-to-use off-the-shelf products including Sensory Neurons, Motor Neurons, Schwann Cell Precursors, Melanocytes, and Dorsal Horn Neurons) paired with differentiation kits that enable researchers to rapidly manufacture these same cell types from human pluripotent stem cells. Anatomic's proprietary technology platform produces Primal Ectoderm within 24 hours and generates immature neurons within seven days—compared to the traditional one-month timeline—creating a shortcut to patterning stages important for neuronal diversity. The company also offers custom differentiation services with a 6-8 week turnaround for researchers requiring bespoke cell production.

Product and service1 record
1Sensory Neurons (Cryopreserved)
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

BrainXell specializes in the differentiation of hiPSCs into neural cell types, including motor neurons and dopaminergic neurons, for research and drug discovery. It is a direct competitor to Anatomic in the hiPSC-derived neural cell market, targeting overlapping academic and pharma customers.

TypeDirect peer
Description

Axol Bioscience produces iPSC-derived neural cells, including sensory neurons, motor neurons, and astrocytes, for research and drug discovery applications. It directly competes with Anatomic across the same customer segments and product categories.

TypeDirect peer
Description

Ncardia develops iPSC-derived cell products and services for drug discovery and cell therapy development, with a strong focus on neural and cardiac cell types. It is a direct peer in the iPSC-derived cell products and custom services market.

TypeBroad incumbent
Description

Cellular Dynamics (a FujiFilm subsidiary) is a leading provider of iPSC-derived cells, including neural cell types, for research, drug discovery, and clinical applications. It is a broad incumbent that overlaps with Anatomic's neural cell product line but operates at significantly greater scale.

TypeEmerging player
Description

bit.bio has developed a proprietary iPSC reprogramming technology (opti-ox) for the rapid generation of human cell types, including neural cells. It represents an emerging competitive threat in the accelerated iPSC differentiation space that Anatomic occupies.

TypeEmerging player
Description

NeuCyte develops iPSC-derived neural cell models and assays for neuroscience drug discovery. It overlaps with Anatomic's neural cell and custom service offerings, particularly for pharma/biotech drug screening applications.

TypeBroad incumbent
Description

STEMCELL Technologies is a major supplier of cell culture media, reagents, and differentiation kits, including products for neural cell differentiation. It competes with Anatomic's differentiation kit product line as a broad life science tools incumbent.

TypeBroad incumbent
Description

Reprocell provides iPSC-derived cell products, reagents, and services for drug discovery and research. It competes with Anatomic in the broader iPSC-derived neural and other cell type markets with a wider product portfolio.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Anatomic

Stem Cell Research Productsanatomic.tech

Anatomic is a Minneapolis biotech (founded 2018) that sells hiPSC-derived neural cells, differentiation kits, and custom services to academic and pharma researchers, using a proprietary protocol that accelerates neuron production to roughly 7 days versus conventional ~1 month timelines.

Anatomic firmographics

Firmographics
Name
Anatomic
Legal name
Anatomic Incorporated
Website
https://anatomic.tech
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Anatomic is a Minneapolis biotech (founded 2018) that sells hiPSC-derived neural cells, differentiation kits, and custom services to academic and pharma researchers, using a proprietary protocol that accelerates neuron production to roughly 7 days versus conventional ~1 month timelines.
Ownership category
akta.pro rank

Anatomic industry classification

Industry
Product category
Stem Cell Research Products
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAAAMAL
Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics

Keywords

  • Stem cell products
  • Neuroscience research tools
  • HiPSC differentiation
  • Pharma research reagents
  • Cell therapy manufacturing

Where Anatomic is headquartered

Location

Headquarters

HQ city
Minneapolis
HQ country
United States
HQ region
North America

Markets served

Anatomic business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Cryopreserved hiPSC-Derived Cells: Sale of off-the-shelf cryopreserved human iPSC-derived neural cells including Sensory Neurons, Motor Neurons, Schwann Cell Precursors, Melanocytes, and Dorsal Horn Neurons for immediate use by researchers.
  2. Differentiation Kits: Human pluripotent stem cell differentiation medium for the rapid manufacture of various neural cell types. Products include Sensory Neuron, Motor Neuron, Schwann Cell Precursor, and Melanocyte differentiation kits.
  3. Custom Differentiation Services: Bespoke cell differentiation services delivering specific neural cell types with rapid 6-8 week turnaround time. Provides Schwann cells, motor neurons, sensory neurons, melanocytes, and dorsal horn neurons to customer specifications.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Anatomic product offering

Product offering

Core offering

Anatomic is a biotechnology company that develops and sells cryopreserved human induced pluripotent stem cell (hiPSC)-derived neural cells and differentiation kits, including sensory neurons, motor neurons, Schwann cell precursors, melanocytes, and dorsal horn neurons, for use by academic and pharmaceutical researchers in basic science and drug discovery. Its proprietary differentiation platform produces Primal Ectoderm within 24 hours and immature neurons within seven days, cutting traditional manufacturing timelines by roughly 75%. The company also offers custom differentiation services with a 6–8 week turnaround for researchers requiring bespoke cell production.

Product overview

Anatomic is a biotech company offering a dual-product portfolio focused on accelerated production of hiPSC-derived neurons and related cell types. The portfolio consists of cryopreserved cells (ready-to-use off-the-shelf products including Sensory Neurons, Motor Neurons, Schwann Cell Precursors, Melanocytes, and Dorsal Horn Neurons) paired with differentiation kits that enable researchers to rapidly manufacture these same cell types from human pluripotent stem cells. Anatomic's proprietary technology platform produces Primal Ectoderm within 24 hours and generates immature neurons within seven days—compared to the traditional one-month timeline—creating a shortcut to patterning stages important for neuronal diversity. The company also offers custom differentiation services with a 6-8 week turnaround for researchers requiring bespoke cell production.

Differentiator

Problem solved

Functional benefit

Products and services

  • Sensory Neurons (Cryopreserved)

Quantifiable outcome

  • Neuron production time reduced from 1 month to 1 week (75% reduction)
  • +2 more outcomes

Companies that use Anatomic

Customer profile

Segments2 records

Ideal customer profiles2 records

Anatomic technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Anatomic partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights5 records

Anatomic competitors and assessment

Company assessment

Direct peers

  • BrainXell: BrainXell specializes in the differentiation of hiPSCs into neural cell types, including motor neurons and dopaminergic neurons, for research and drug discovery. It is a direct competitor to Anatomic in the hiPSC-derived neural cell market, targeting overlapping academic and pharma customers.
  • Axol Bioscience: Axol Bioscience produces iPSC-derived neural cells, including sensory neurons, motor neurons, and astrocytes, for research and drug discovery applications. It directly competes with Anatomic across the same customer segments and product categories.
  • Ncardia: Ncardia develops iPSC-derived cell products and services for drug discovery and cell therapy development, with a strong focus on neural and cardiac cell types. It is a direct peer in the iPSC-derived cell products and custom services market.

Broad incumbents

  • FujiFilm Cellular Dynamics: Cellular Dynamics (a FujiFilm subsidiary) is a leading provider of iPSC-derived cells, including neural cell types, for research, drug discovery, and clinical applications. It is a broad incumbent that overlaps with Anatomic's neural cell product line but operates at significantly greater scale.
  • STEMCELL Technologies: STEMCELL Technologies is a major supplier of cell culture media, reagents, and differentiation kits, including products for neural cell differentiation. It competes with Anatomic's differentiation kit product line as a broad life science tools incumbent.
  • Reprocell: Reprocell provides iPSC-derived cell products, reagents, and services for drug discovery and research. It competes with Anatomic in the broader iPSC-derived neural and other cell type markets with a wider product portfolio.

Emerging players

  • bit.bio: bit.bio has developed a proprietary iPSC reprogramming technology (opti-ox) for the rapid generation of human cell types, including neural cells. It represents an emerging competitive threat in the accelerated iPSC differentiation space that Anatomic occupies.
  • NeuCyte: NeuCyte develops iPSC-derived neural cell models and assays for neuroscience drug discovery. It overlaps with Anatomic's neural cell and custom service offerings, particularly for pharma/biotech drug screening applications.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Anatomic social profiles

Digital presence

Anatomic financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Anatomic leadership team

Management profile

Number of profiles

Anatomic funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Anatomic M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Anatomic

What does Anatomic do?

Anatomic is a biotechnology company that develops and sells cryopreserved human induced pluripotent stem cell (hiPSC)-derived neural cells and differentiation kits, including sensory neurons, motor neurons, Schwann cell precursors, melanocytes, and dorsal horn neurons, for use by academic and pharmaceutical researchers in basic science and drug discovery. Its proprietary differentiation platform produces Primal Ectoderm within 24 hours and immature neurons within seven days, cutting traditional manufacturing timelines by roughly 75%. The company also offers custom differentiation services with a 6–8 week turnaround for researchers requiring bespoke cell production.

Is Anatomic a public or private company?

Anatomic is a private company. It is classified as unknown and is currently operating.

When was Anatomic founded?

Anatomic was founded in 2018. It employs 11 to 50 people.

Where is Anatomic based?

Anatomic is headquartered in Minneapolis, United States, in the North America region.

How does Anatomic make money?

Three revenue lines are on record. Cryopreserved hiPSC-Derived Cells are the primary driver. The others are differentiation Kits and custom Differentiation Services.

Who are Anatomic's main competitors?

Direct peers on record are BrainXell, Axol Bioscience and Ncardia. Broad incumbents are FujiFilm Cellular Dynamics, STEMCELL Technologies and Reprocell. Emerging players are bit.bio and NeuCyte.

Does Anatomic have an API?

No public API is recorded for Anatomic.

What industry is Anatomic in?

Anatomic's product category is Stem Cell Research Products. Its primary akta.pro industry code is HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls). Its NAICS code is 541714 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales